Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer.

Saved in:
Bibliographic Details
Title: Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer.
Authors: Burcombe, R. J.1, Makris, A.1 andreas.makris@whht.nhs.uk, Richman, P. I.1, Daley, F. M.2, Noble, S.2, Pittam, M.3, Wright, D.3, Allen, S. A.3, Dove, J.3, Wilson, G. D.2
Source: British Journal of Cancer. 1/17/2005, Vol. 92 Issue 1, p147-155. 9p.
Database: Academic Search Ultimate
Description
ISSN:00070920
DOI:10.1038/sj.bjc.6602256